[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"muscle-strength-recovery\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:muscle-strength-recovery":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,56],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":33,"overallStatus":43,"whyStopped":4,"lastUpdateSubmitDate":44,"lastUpdatePostDateStruct":45,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":55},"100638836","whey-protein-and-adaptogenic-supplementation-in-physically-active-females-100638836",false,"NCT07594444","Whey Protein and Adaptogenic Supplementation in Physically Active Females","Whey Protein and Adaptogenic Herb Supplementation in Physically Active Females: A Randomised Controlled Trial","Inclusion Criteria:\n\n* Female, aged 18-45 years\n* Currently participating in regular structured athletic or physical training (≥3 sessions per week)\n* Free from musculoskeletal injury that would prevent testing\n* Willing to maintain usual diet and training habits during the study\n* Not currently using protein supplements or adaptogenic supplements\n\nExclusion Criteria:\n\n* Pregnant, breastfeeding, or planning pregnancy during the study period\n* Known allergy or sensitivity to dairy, pea protein, pumpkin seed, chia seed, ashwagandha, shatavari, or nightshades\n* Current use of prescribed medication that may interact with the supplements\n* Thyroid disorders, autoimmune conditions, hormone-sensitive conditions, or other medical conditions that may be affected by supplementation\n* Diagnosed eating disorder or condition affecting protein metabolism\n* Current musculoskeletal injury preventing participation in testing\n* Current use of other protein supplements or adaptogens",true,"FEMALE","18 Years","45 Years",{"count":21,"type":22},60,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this clinical trial is to learn whether whey protein or plant protein supplements, with or without an adaptogenic herb blend, can improve strength, recovery, stress, and wellbeing in active females. The adaptogenic blend contains ashwagandha root extract and shatavari root extract.\n\nThe main questions the study aims to answer are:\n\n* Do whey protein and plant protein supplements improve muscle strength and recovery in physically active females?\n* Does adding ashwagandha and shatavari improve stress, recovery, sleep, and wellbeing compared with protein alone?\n* Are there differences between whey protein and plant protein when combined with the adaptogenic blend?\n\nResearchers will compare four supplement groups:\n\n* Whey protein\n* Whey protein with ashwagandha and shatavari\n* Plant protein\n* Plant protein with ashwagandha and shatavari\n\nParticipants will:\n\n* Take their assigned supplement daily for 6 weeks\n* Attend testing sessions before and after the intervention\n* Complete questionnaires about recovery, sleep, stress, soreness, and digestive health\n* Provide saliva samples to measure stress, hormone, immune, and inflammation markers\n* Complete muscle strength tests, including handgrip strength and push-up testing\n* Complete a 24-hour dietary recall. The study includes physically active females aged 18 to 45 years who regularly participate in structured training.",[28,29,30,31,32],"Sports Nutritional Sciences","Recovery","Muscle Strength Recovery","Muscle Strength","Supplements",[34,35,36,37,38,39,40,41,42],"Whey Protein","Plant protein","Ashwagandha","Shatavari","Adaptogens","Sports","Exercise","Active females","physically active females","RECRUITING","2026-06-03",{"date":46,"type":47},"2026-06-05","ACTUAL",{"date":49,"type":22},"2026-07-01",{"date":51,"type":22},"2026-09-20",{"name":53,"class":54},"Sports Performance and Applied Research in Trials and Analysis","NETWORK",1,{"id":57,"slug":58,"hasResults":11,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":4,"eligibilityCriteria":62,"healthyVolunteers":16,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":4,"studyType":23,"phases":68,"briefSummary":69,"conditions":70,"keywords":4,"overallStatus":73,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":4},"100600071","efficacy-of-ln18178-in-improving-muscle-strength-aerobic-capacity-and-body-composition-in-healthy-young-males-100600071","NCT07092722","Efficacy of LN18178 in Improving Muscle Strength, Aerobic Capacity and Body Composition in Healthy Young Males","A Randomized, Double Blind, Placebo Controlled Parallel Arm Clinical Study to Evaluate the Efficacy of LN18178 in Improving Muscle Strength, Aerobic Capacity and Body Composition in Healthy Young Males","Inclusion Criteria:\n\n1. Untrained healthy male subjects aged between 36 and 50 years with a Body Mass Index (BMI) between 22 and 27 kg\u002Fm2.\n2. Willingness to do exercise training program during the course of the study.\n3. Subject considered generally healthy as per health history and routine clinical investigations.\n4. Ability to understand the risks and benefits of the protocol.\n5. Subject should provide written informed consent and agree to be available for regular follow up throughout the study duration.\n6. Subjects who are sexually active must agree to use adequate non-hormonal contraception during the study\n7. Subjects agree to maintain current diet and activity level.\n8. Subject agrees not to start any new therapies for energy boosting supplements or protein supplements or health drinks during the course of the study.\n9. Subjects willing to refrain from drinking coffee or caffeinated drinks or beverages during the study.\n\nExclusion Criteria:\n\n1. Subjects who are resistance trained or undergoing resistance training.\n2. Subjects with blood pressure more than or equal to 140\u002F90 mmHg, fasting plasma glucose more than 125 mg\u002FdL and abnormal ECG.\n3. Subjects underwent treatment for COVID-19 within last 3 months or tested positive during the study will be excluded.\n4. Evidence or history of musculoskeletal, respiratory, haematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, neurologic diseases, malignancies.\n5. Subjects diagnosed with sleep apnea or related disorders.\n6. Subjects consuming medications that can interfere with muscle mass such as corticosteroids, testosterone replacement or anabolic drugs.\n7. History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.\n8. Subjects consuming alcohol (more than 3 standard drinks per week) or smokers ( more than 3 cigarettes per day).\n9. Subjects who consume recreational drugs (such as cocaine, methamphetamine, marijuana, etc.) or chewable tobacco products.\n10. Subjects under medications including anti-hypertensives, antidepressants, anticholinergics, inhaled beta agonists, anti-hyperlipidemics, psychotropics etc.\n11. Subjects using any centrally acting anorectic agents, drugs that inhibit the absorption of nutrients and endocannabinoid neuromodulators during the two weeks prior to enrolment into the study.\n12. Subjects who underwent major surgical procedures in last 6 months.\n13. Subject with HIV positive or history of any other STDs.\n14. Subject has participated in a clinical study within the last 30 days prior to recruitment or concurrently participating in another study\n\n    \\-","MALE","36 Years","50 Years",{"count":67,"type":22},120,[25],"The Purpose of the study is to evaluate the efficacy of LN18178 in improving muscle strength, aerobic capacity and body composition in healthy young males.",[30,71,72],"Endurance","Healthy Human Volunteers","NOT_YET_RECRUITING","2025-07-29",{"date":76,"type":47},"2025-07-30",{"date":78,"type":22},"2025-08-04",{"date":80,"type":22},"2026-01-15",{"name":82,"class":83},"GENCOR Lifestage Solutions","OTHER"]